首页> 外文期刊>International Journal of Biosciences >An Evaluation of dark sesame seeds versus white sesame on blood glucose, oxidative stress markers, and kidney function in streptozotocin-induced diabetic rats
【24h】

An Evaluation of dark sesame seeds versus white sesame on blood glucose, oxidative stress markers, and kidney function in streptozotocin-induced diabetic rats

机译:黑芝麻与白芝麻对链脲佐菌素诱导的糖尿病大鼠血糖,氧化应激指标和肾功能的评估

获取原文
           

摘要

Sesame seeds have been the focus of recent studies due to their potential nutritional value and chemical composition. Forty-eight albino Sprague Dawley rats were divided into 4 groups (12 rats each in group):Group 1—the normal control group, Group 2—the diabetic control group, Group 3—the diabetic group that received the standard diet+15% dark sesame seeds, and Group 4—the diabetic group that received the standard diet+15% white sesame seeds for 6 weeks. Diabetes was induced by a single dose of streptozotocin (60 mg/kg body weight).The levels of blood glucose, (MDA) malondialdehyde, serum creatinine, urea, and Uric acid were statistically lower in G3 and G4 than in G2 (P0.05). Total antioxidants (TAC) were statistically higher in G3 and G4 than in G2 (P0.05).No significant difference was found between G3 and G4 in blood glucose. However, G3 showed a significant improvement in MDA and TAC, serum creatinine, urea, and uric acidcompared to G4 (P0.05). Consuming both dark and white sesame seeds can improve blood glucose, oxidative stress markers and kidney function in streptozotocin-induced diabetic rats. Therefore, sesame seeds area potential protective natural agent against diabetes complications.
机译:芝麻种子由于其潜在的营养价值和化学成分而成为近期研究的重点。将48只白化病Sprague Dawley大鼠分为4组(每组12只大鼠):第1组-正常对照组,第2组-糖尿病对照组,第3组-接受标准饮食+ 15%的糖尿病组深色芝麻,以及第4组-糖尿病组,接受标准饮食+ 15%白芝麻种子,持续6周。单剂量链脲佐菌素(60 mg / kg体重)可诱发糖尿病.G3和G4的血糖,丙二醛(MDA)丙二醛,血清肌酐,尿素和尿酸水平在统计学上低于G2(P < 0.05)。 G3和G4中的总抗氧化剂(TAC)在统计学上高于G2(P <0.05).G3和G4之间的血糖差异无统计学意义。然而,与G4相比,G3在MDA和TAC,血清肌酐,尿素和尿酸方面有显着改善(P <0.05)。同时摄取黑芝麻和白芝麻可以改善链脲佐菌素诱发的糖尿病大鼠的血糖,氧化应激指标和肾脏功能。因此,芝麻籽是潜在的天然抗糖尿病并发症的保护剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号